Financials

  • Market Capitalization 40.03 M
  • Employee 5
  • Founded 2002
  • CEO N/A
  • Website www.gracetx.com
  • Headquarter Delaware, United States
  • FIGI BBG001NMDXS6
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-9.85
Rapporto prezzo/fatturato
-76.44 K

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4364
PDSB
PDS Biotechnology Corporation - Common Stock
0.75 USD0.00%-9.64%-30.56%-38.52%41.86 M USD
4377
ACTU
Actuate Therapeutics, Inc. - Common stock
1.73 USD+15.33%+16.89%-19.16%-57.60%41.39 M USD
4394
RNXT
RenovoRx, Inc. - Common Stock
0.85 USD-6.59%-7.61%+1.19%-38.41%38.33 M USD
4395
NNVC
NanoViricides, Inc. Common Stock
1.77 USD+7.27%+19.59%+36.15%+75.23%38.32 M USD